Company Spotlight

BioTechnique

Aphena Pharma Solutions

1920 Fisk Road
Cookeville, TN 38506
United States
View Profile

Almac Group

Almac House, 20 Seagoe Industrial Estate
Armagh, BT63 5QD
United Kingdom
View Profile


Contract Service Directory


Groupe Parima





Company Headquarters

4450 Cousens
Montreal, QC H4S 1X6
Canada

Company Description

Groupe PARIMA is a CDMO established in 1994. Over the years, we have developed an expertise in the development and manufacturing of non-sterile liquids, suspensions and semi-solid drug products. We work hand-in-hand with our clients to customize our services to meet their needs. From full turn-key services to highly collaborative development projects, we can adapt to fit your operational requirements. We have been favorably inspected by the EMA, TMMDA, FDA and Health Canada, and we currently manufacture products for markets around the globe.

Contract Service Directory

    Related Content

    • Contract Pharma’s 18th Conference & Tabletop Exhibit Was a Another Success!

      Contract Pharma’s 18th Conference & Tabletop Exhibit Was a Another Success!

      Contracting & Outsourcing 2019 featured a sold-out exhibit hall and lively conference sessions.
      10.22.19

    • Breaking News
      Contract Pharma’s 18th Conference & Tabletop Exhibit Was a Another Success!

      Contract Pharma’s 18th Conference & Tabletop Exhibit Was a Another Success!

      Contracting & Outsourcing 2019 featured a sold-out exhibit hall and lively conference sessions.
      10.18.19

    • Regulatory Affairs | Serialization
      Fighting Back!

      Fighting Back!

      The drug industry takes a bare-knuckle approach to drug counterfeiters.
      Daniela Geiger, Vetter 10.04.19


    • VIDEO: Contract Pharma 2019 Video Highlights!

      VIDEO: Contract Pharma 2019 Video Highlights!

      Contracting & Outsourcing 2019 featured a sold-out exhibit hall and lively conference sessions.
      10.02.19


    • Biologics, Proteins, Vaccines | Injectables
      A World of Innovation

      A World of Innovation

      The importance of innovation in the injectable business and the hurdles a CDMO faces
      Claudia Roth, Vetter Pharma-Fertigung GmbH & Co. KG 11.07.17


    • Industry News
      CPhI Report Highlights Anticipated CDMO Market Trends

      CPhI Report Highlights Anticipated CDMO Market Trends

      Niche services and technologies to dominate future acquisitions, increase in flow chemistry, fermentation anticipated
      10.17.17

    • Drug Delivery Innovation

      Growth in biologics is driving advanced drug delivery technology solutions
      Tim Wright, Editor 10.11.17

    • Bio News | Bioanalytical Services | Breaking News | Drug Discovery | Industry News | Preclinical Outsourcing
      ABL Acquisition Extends Ardena’s Early-phase Offering

      ABL Acquisition Extends Ardena’s Early-phase Offering

      Broadens the CDMO’s pre-clinical and clinical offering to include bioanalytical and drug discovery services.
      10.10.17


    • 2017 Contracting & Outsourcing Conference Wrap up

      2017 Contracting & Outsourcing Conference Wrap up

      Another year of record attendance, sold-out exhibit hall, and sessions addressing key industry topics
      10.06.17

    • Breaking News | Clinical Trial Materials | Drug Development | Industry News
      Ardena Launches following Pharmavize and Crystallics Merger

      Ardena Launches following Pharmavize and Crystallics Merger

      Will offer solid-state chemistry, analytical and formulation development, and early-phase clinical supply manufacturing
      09.11.17

    • Aseptic Processing | Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News | Injectables
      Amatsigroup Manufactures Injectable Clinical Batch Under Single-Use Isolator

      Amatsigroup Manufactures Injectable Clinical Batch Under Single-Use Isolator

      French CDMO develops innovative single-use technology solutions for aseptic formulation & manufacturing
      09.05.17


    • 25	Otsuka

      25 Otsuka

      ...
      07.24.17

    • Bio News | Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
      Eurofins to Acquire Amatsigroup for $150M

      Eurofins to Acquire Amatsigroup for $150M

      Expands position in biopharmaceutical services
      07.12.17